TY - JOUR
T1 - Community study to uncover the full spectrum of rheumatic heart disease in Uganda
AU - Scheel, Amy
AU - Ssinabulya, Isaac
AU - Aliku, Twalib
AU - Bradley-Hewitt, Tyler
AU - Clauss, Alexa
AU - Clauss, Sarah
AU - Crawford, Lexi
AU - Dewyer, Alyssa
AU - Donofrio, Mary T.
AU - Jacobs, Marni
AU - Klein, Jennifer
AU - Moore, Teresa E.
AU - Okello, Emmy
AU - Scheel, Janet
AU - Shaw, Rebekah
AU - Sable, Craig
AU - Lwabi, Peter
AU - Watkins, David A.
AU - Beaton, Andrea
N1 - Funding Information:
Funding this study was supported with a grant from the Karp Family Foundation and children’s national global health initiative.
Publisher Copyright:
© © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Objective Estimates of the prevalence of rheumatic heart disease (RHD) in many endemic countries are limited to samples of children attending schools, which generate an incomplete picture of disease burden in communities. The present study conducted household-based RHD screening in a representative community in Gulu district, Uganda. Methods Members of households identified through a two-stage cluster-sampling approach between the ages of 5 years and 50 years were invited to undergo limited cardiac testing with a handheld echocardiogram to assess for the presence of RHD. Suspicious cases underwent confirmatory echocardiogram with a fully functional machine. Results Of the 2453 community members screened, 2.45% (95% CI 1.87% to 3.14%) showed echocardiographic evidence of RHD with 1.26% (95% CI 0.860% to 1.79%) having definite RHD. The overall prevalence of RHD among participants <20 years was 2.52% (95% CI 1.78% to 3.45%), with a borderline prevalence of 1.97% (95% CI 1.33% to 2.82%) and a definite prevalence of 0.544% (95% CI 0.235% to 1.07%). Prevalence rates among youth increased with age and peaked in the age group of 16-20 years. The overall adult prevalence (>20 years) of RHD was 2.34% (95% CI 1.49% to 3.49%). The majority of definite cases were mild (81%) and marked by mitral regurgitation and associated morphological valve changes (71%). Conclusion Our data reveal a high prevalence of undiagnosed RHD within an endemic community and fill a critical gap in RHD epidemiology in African adults.
AB - Objective Estimates of the prevalence of rheumatic heart disease (RHD) in many endemic countries are limited to samples of children attending schools, which generate an incomplete picture of disease burden in communities. The present study conducted household-based RHD screening in a representative community in Gulu district, Uganda. Methods Members of households identified through a two-stage cluster-sampling approach between the ages of 5 years and 50 years were invited to undergo limited cardiac testing with a handheld echocardiogram to assess for the presence of RHD. Suspicious cases underwent confirmatory echocardiogram with a fully functional machine. Results Of the 2453 community members screened, 2.45% (95% CI 1.87% to 3.14%) showed echocardiographic evidence of RHD with 1.26% (95% CI 0.860% to 1.79%) having definite RHD. The overall prevalence of RHD among participants <20 years was 2.52% (95% CI 1.78% to 3.45%), with a borderline prevalence of 1.97% (95% CI 1.33% to 2.82%) and a definite prevalence of 0.544% (95% CI 0.235% to 1.07%). Prevalence rates among youth increased with age and peaked in the age group of 16-20 years. The overall adult prevalence (>20 years) of RHD was 2.34% (95% CI 1.49% to 3.49%). The majority of definite cases were mild (81%) and marked by mitral regurgitation and associated morphological valve changes (71%). Conclusion Our data reveal a high prevalence of undiagnosed RHD within an endemic community and fill a critical gap in RHD epidemiology in African adults.
KW - global disease patterns
KW - valvular heart disease
UR - http://www.scopus.com/inward/record.url?scp=85050950439&partnerID=8YFLogxK
U2 - 10.1136/heartjnl-2018-313171
DO - 10.1136/heartjnl-2018-313171
M3 - Article
C2 - 30068532
AN - SCOPUS:85050950439
SN - 1355-6037
VL - 105
SP - 60
EP - 66
JO - Heart
JF - Heart
IS - 1
ER -